ID   293C18P
SY   293 C18P
DR   CCRID; 4201PAT-CCTCC01329
DR   Wikidata; Q108819498
RX   Patent=CN110438066B;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201913.
CC   Transfected with: UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 6
RX   Patent=CN110438066B;
RA   Li M.-Z., Zhang P., Hu M., Cai N.;
RT   "Mammalian cell line 293C18P capable of being stably passaged and
RT   capable of being cultured in suspension, and preparation method and
RT   application thereof.";
RL   Patent number CN110438066B, 12-Jan-2021.